AllPennyStocks.com New Jersey-Based Biotech Company Finds Massive Mid-Week Success ...
AllPennyStocks.com

New Jersey-Based Biotech Company Finds Massive Mid-Week Success Following "Positive Feedback"

New Jersey-Based Biotech Company Finds Massive Mid-Week Success Following "Positive Feedback" By: Dylan Sikes – AllPennyStocks.com News

Wednesday, October 30, 2024

Big news out of New Jersey this morning as a biotech company said it received “positive feedback” from the European Medicines Agency about TH104, its candidate to treat moderate-to-severe pruritus in primary biliary cholangitis, or PBC, according to a release. 

Traders were in a rush to grab up shares of Tharimmune Inc. (Nasdaq:THAR) following the news, with shares of this micro cap currently trading around $4.08/share (+100.99%) at the time of writing. This move was a strong breakout of a multi-month downtrend that this stock has been stuck in, which could be an indication of things to come. Keep your eye on this one!

Tharimmune, Inc. is a clinical-stage biotechnology company developing a diverse portfolio of therapeutic candidates in immunology and inflammation. The lead clinical asset, TH104, aims to suppress chronic pruritus associated with primary biliary cholangitis (PBC), a rare autoimmune liver disease with no known cure. The expanded pipeline includes TH023, an oral TNF-alpha inhibitor, offering a new approach to treating autoimmune diseases. Tharimmune is also advancing early-stage multi-specific biologics targeting unique epitopes against multiple solid tumors. The company has a license agreement with OmniAb, Inc. to access their antibody discovery technology for targeting specified disease markers. 


Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

New Advisor Lifts Shares of this Company That Leverages Opportunities in Solana-Based Projects
 Read More
California-Based Biotech Trading over +200% Premarket Following Acquisition Announcement
 Read More
Shares Take Off Following Binding Offtake Agreement
 Read More
Most Popular
1
Shares Take Off Following Binding Offtake Agreement
2
New Advisor Lifts Shares of this Company That Leverages Opportunities in Solana-Based Projects
3
U.S. Housing Starts Trend Down, Existing Sales Recover
4
Strategic Acquisition Sending Shares of Junior Miner Higher
5
Washington Curtails Intel’s Chip Grant After Company Stumbles
6
After Russian ship docks to space station, astronauts report a foul smell - Ars Technica


Back to Top
Site Links:
Premium Services / Email Newsletter:
Social Media:
RSS Feed:
Partners:
© Copyright 2024 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.
© Copyright 1999 – 2024. AllPennyStocks.com Media Inc.
All rights reserved.